COVID-19 treatment

Indianapolis-based Eli Lilly is partnering with health care systems around the state to increase access and affordability around its COVID-19 antibody…

The Food and Drug Administration (FDA) has given emergency authorization to Eli Lilly for its COVID-19 antibody drug bamlanivimab.The Indianapolis-based…

The U.S. government has agreed to purchase 300,000 doses of Eli Lilly’s COVID-19 antibody treatment. It plans to pay $375 million for the vials of the…

Indiana’s State Health Commissioner says a COVID-19 vaccine could be available for some Hoosiers as early as mid to late November.Dr. Kris Box said…

Indianapolis-based Eli Lilly has ended testing its COVID-19 antibody therapy on hospitalized patients. Earlier this month, Eli Lilly temporarily suspended…

State health leaders are beginning to release their plans for distributing a COVID-19 vaccine — whenever one becomes available. All states were required…

Eli Lilly paused trials of its COVID-19 treatment drug Tuesday. The news came less than a day after Johnson & Johnson also paused its trial on a COVID-19…

Indianapolis-based Eli Lilly has requested emergency use authorization (EUA), from the Food and Drug Administration (FDA), for it’s COVID-19 single…

Indianapolis-based Eli Lilly announced Wednesday its COVID-19 antibody drug is showing results in reducing hospitalizations from the virus. This is the…

The Indiana State Department of Health reported 60 additional confirmed deaths over the last week, bringing the state’s total to 2,835. The state…